Man City Agrees New Mundipharma Deal
Mundipharma and English Premier League side Manchester City have agreed to a new global partnership following an inaugural first season that saw Mundipharma and BETADINE perform as a regional partner of Manchester City.
Under the terms of the global partnership, the Manchester City medical team’s uniform and kit will feature BETADINE logos and they’ll be equipped with BETADINE treatments for the players. The brand will also benefit from enhanced exposure on digital display formats at home games.
Mundipharma will continue to collaborate with Manchester City to provide aspiring footballers with opportunities to develop their skills as part of co-branded youth development programmes, as well as offering fans the chance to see their heroes in action through consumer-based promotions.
Commenting on the new global partnership, Mundipharma CEO, Raman Singh, said: “This partnership has proven to be a great fit for our brands. Manchester City is one of the world’s best-performing football teams, while we have positioned BETADINE as a healthcare portfolio that builds personal resilience and supports well-being.
“Football is a powerful and emotive way to engage with people and communicate messages about personal healthcare and well-being in a way that is relevant and taps into the emotional fan experience. Manchester City’s success and continued ambition provides a global platform and extraordinary reach. Football is the language the world speaks.”
Tom Glick, chief commercial officer of City Football Group, added: “We are extremely pleased to have extended our partnership with Mundipharma and BETADINE. They have been a great partner from the outset. We have been continually impressed by the creative approach they have brought to everything we have done so far. We are delighted that we now have an opportunity to work together on a global scale.”
Earlier this year, Mundipharma announced a partnership with J1 League club, Yokohama F. Marinos, which is also part of City Football Group.
